FIB-4 score as a predictor of mortality outcomes in individuals with metabolic dysfunction-associated steatotic liver disease with moderate alcohol consumption: a nationwide cohort study

被引：0
|
作者：
Aboona, Majd [1 ]
Danpanichkul, Pojsakorn [2 ]
Chen, Vincent [3 ]
Rangan, Pooja [1 ]
Kim, Donghee [4 ]
Alkhouri, Naim [5 ]
Noureddin, Mazen [6 ,7 ]
Arab, Juan Pablo [8 ,9 ,10 ]
Wijarnpreecha, Karn [1 ,11 ,12 ]
机构：
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Chiang Mai Univ, Chiang Mai, Thailand
[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] Arizona Liver Hlth, Chandler, AZ USA
[6] Houston Res Inst, Houston, TX USA
[7] Houston Methodist Hosp, Houston, TX USA
[8] Pontificia Univ Catolica Chile, Santiago, Chile
[9] Western Univ, London, ON, Canada
[10] London Hlth Sci Ctr, London, ON, Canada
[11] Banner Univ, Med Ctr, Phoenix, AZ USA
[12] Univ Arizona, Coll Med, BIO5 Inst, Phoenix, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-278
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [41] Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study
    Charatcharoenwitthaya, Phunchai
    Karaketklang, Khemajira
    Aekplakorn, Wichai
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] New insights into metabolic dysfunction-associated steatotic liver disease and oxidative balance score
    Peng, Lei
    Li, Lurong
    Liu, Jiahao
    Li, Yuanyuan
    FRONTIERS IN NUTRITION, 2024, 10
  • [43] Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study
    Park, Min Kyung
    Hur, Moon Haeng
    Moon, Hye-Sung
    Shin, Hyunjae
    Chung, Sung Won
    Won, Sungho
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    LIVER INTERNATIONAL, 2024, 44 (03) : 799 - 810
  • [44] Distinct characteristics of MetALD (metabolic dysfunction-associated steatotic liver disease with greater alcohol consumption) in the general population
    Yoon, Eileen L.
    Park, Huiyul
    Hong, Han Pyo
    Lee, Chul-Min
    Kim, Mimi
    Kang, Bo-Kyeong
    Jun, Dae Won
    HEPATOLOGY RESEARCH, 2025, 55 (03) : 410 - 421
  • [45] Clinical Outcomes among Nondiabetic Obese Population with Concomitant Metabolic Dysfunction-Associated Steatotic Liver Disease-A Nationwide Study
    Kishore, Sindhu
    Khokhlov, Leonid
    Mateo, Fernando R.
    Rajbhandari, Pranita
    Ikpeze, Tochukwu
    Kishore, Mehwish
    Ajenaghughrure, Godbless E.
    Thapa, Anup
    DIABETES, 2024, 73
  • [46] MAGNESIUM DEPLETION SCORE AND MORTALITY IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE OVER A MEDIAN FOLLOW-UP OF 14 YEARS
    Zhu, Xiangzhu
    Zhang, Xinyuan
    Salvador, Shakirat
    Zhang, Xuehong
    Shrubsole, Martha
    Izzy, Manhal
    Dai, Qi
    HEPATOLOGY, 2024, 80 : S913 - S913
  • [47] The impact of light to moderate alcohol consumption on liver and cardiovascular damage in metabolic-dysfunction associated steatotic liver disease
    Lombardi, Rosa
    Cinque, Felice
    Dalbeni, Andrea
    Cespiati, Annalisa
    Santomenna, Floriana
    Curra, Jaqueline
    Smith, Daniel
    Fatta, Erika
    Bertelli, Cristina
    Pisano, Giuseppina
    Pulixi, Edoardo
    Mantovani, Anna
    Zoncape, Mirko
    Sacerdoti, David
    Fracanzani, Anna Ludovica
    JOURNAL OF HEPATOLOGY, 2024, 80 : S474 - S474
  • [48] Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Fujmoto, Shota
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Tanaka, Hironori
    Kida, Yoshifumi
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)
  • [49] High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease
    Hu, Jingjing
    Du, Yuteng
    Zhou, Yidan
    Wang, Huiying
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
    Dong, Rui
    Tian, Ting
    Luo, Zhenghan
    Chang, Dongchun
    Xue, Hong
    Qu, Sen
    Wang, Jia
    Shen, Chao
    Zhang, Ru
    Wang, Jie
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
12345